Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 16, 2022
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
[ Fri, Dec 16th 2022
] - WOPRAI
Michael Ulz Downgraded (THRD) to Hold and Decreased Target to $5 on, Dec 16th, 2022
Michael Ulz of Morgan Stanley, Downgraded "Third Harmonic Bio, Inc." (THRD) to Hold and Decreased Target from $34 to $5 on, Dec 16th, 2022.
Michael has made no other calls on THRD in the last 4 months.
There is 1 other peer that has a rating on THRD. Out of the 1 peers that are also analyzing THRD, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- Joseph Thome of "Cowen & Co." Initiated at Buy on, Monday, October 10th, 2022
